Additionally, Fam210b is associated with a variety of tumors, such as those of ovarian cancer, breast cancer, lung cancer, and hepatocellular carcinoma, which can inhibit tumor growth and migration by affecting metabolic reprogramming and the extracellular signal-regulated kinase (ERK)– Protein kinase B (PKB, also known as AKT) protein pathway [15]. Here, MIMS2 is linked to neoplasm.